Industries

Specialised for every product type entering Europe and the US.

A small molecule, a cell therapy and a device need different evidence and pathways in Europe and the US. We assess the product, its intended use and the expertise required for the engagement.

PharmaEMA · NCAs · GMP
BiotechATMPs · Biologics
Medical DevicesMDR · IVDR · CE
Beyond the categories

Combination products, diagnostics and digital health.

Many of the most interesting products don't fit neatly into one regulatory box. Drug-led combinations, companion diagnostics and software as a medical device require a product-specific assessment of medicinal-product and device requirements.

Kaiveo Medical scopes these cases individually, bringing the right mix of regulatory, clinical and quality expertise to a single plan.

Discuss a hybrid product

Drug–device combinations

Article 117 assessment for integral products where applicable; CE requirements for co-packaged devices.

Companion diagnostics

IVDR performance evaluation aligned with the medicinal-product development plan.

Software & AI as a medical device

MDR classification, clinical evaluation and cybersecurity expectations for SaMD.

Emerging modalities

Novel platforms where the regulatory route is still being defined.

Your industry

Tell us what you're bringing to market.

A founder will review your product needs and the expertise required before an engagement is agreed.

We aim to reply within two working days. Language support is agreed for each engagement.